Penn Capital Management Company, LLC
Position in ANIP — Ani Pharmaceuticals Inc
CIK 1158202
PHILADELPHIA, PA
Position in ANIP
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$17,165,426
+$3,345,266 QoQ
Shares Held
207,362
+15.4% QoQ
Ownership
0.903%
of shares outstanding
% of Portfolio
1.09%
of 13F equity value
Holder Rank
#36
of 305 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANIP Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Penn Capital Management Company, LLC holds $80,501,316 across 6 Drug Manufacturers - Specialty & Generic names. ANIP ranks #3 (21.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
368,114 | $23,540,890 | |
| 2 | AMRX |
Amneal Pharmaceuticals, Inc.
|
1,181,176 | $20,446,156 | |
| 3 | ANIP |
Ani Pharmaceuticals Inc
This page
|
207,362 | $17,165,426 | |
| 4 | LNTH |
Lantheus Holdings, Inc.
|
153,877 | $17,071,114 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
10,600 | $1,786,524 | |
| 6 | XERS |
Xeris Biopharma Holdings, Inc.
|
62,021 | $491,206 |
All Filings in ANIP
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,165,426 | 207,362 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $13,820,160 | 179,716 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $10,845,882 | 137,394 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $582,942 | 6,364 | Shares | Sole | 2025-11-24 | |
| 2025-06-30 | $389,999 | 5,977 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $448,297 | 6,696 | Shares | Sole | 2025-05-14 | |
| No filing history on record for this holder in this stock. | ||||||